These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
3. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction. Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731 [TBL] [Abstract][Full Text] [Related]
6. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction. van Empel VP; Mariani J; Borlaug BA; Kaye DM J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660 [TBL] [Abstract][Full Text] [Related]
7. Hypertension as a Road to Treatment of Heart Failure with Preserved Ejection Fraction. Hicklin HE; Gilbert ON; Ye F; Brooks JE; Upadhya B Curr Hypertens Rep; 2020 Sep; 22(10):82. PubMed ID: 32880741 [TBL] [Abstract][Full Text] [Related]
8. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356 [TBL] [Abstract][Full Text] [Related]
9. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction. Tam MC; Lee R; Cascino TM; Konerman MC; Hummel SL Curr Hypertens Rep; 2017 Feb; 19(2):12. PubMed ID: 28233237 [TBL] [Abstract][Full Text] [Related]
10. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics. Ben-Nun D; Buja LM; Fuentes F Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211 [TBL] [Abstract][Full Text] [Related]
11. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629 [TBL] [Abstract][Full Text] [Related]
12. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor? Elgendy IY; Pepine CJ Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452 [TBL] [Abstract][Full Text] [Related]
13. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats. Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258 [TBL] [Abstract][Full Text] [Related]
14. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439 [TBL] [Abstract][Full Text] [Related]
15. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction. Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862 [TBL] [Abstract][Full Text] [Related]
16. The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? Tadic M; Cuspidi C; Frydas A; Grassi G Heart Fail Rev; 2018 Sep; 23(5):631-639. PubMed ID: 29619635 [TBL] [Abstract][Full Text] [Related]
17. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball. Tschöpe C; Van Linthout S; Kherad B Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481 [TBL] [Abstract][Full Text] [Related]
18. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction. Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688 [TBL] [Abstract][Full Text] [Related]
19. [The role of inflammation in heart failure with preserved ejection fraction]. Zhang Q; Chen YE; Zhu XX; Wang X; Qu AJ Sheng Li Xue Bao; 2023 Jun; 75(3):390-402. PubMed ID: 37340648 [TBL] [Abstract][Full Text] [Related]
20. Myocardial reverse remodeling: how far can we rewind? Rodrigues PG; Leite-Moreira AF; Falcão-Pires I Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]